Notably, eczema is a common adverse effect of anti-TNF-α therapy that has been reported in up to 20% of patients receiving long-term treatment for psoriasis, arthritis, or inflammatory bowel disease32–34. Here, TNF is linked to Eczematoid dermatitis.